Prospective exosome-focused translational research for afatinib study of non-small cell lung cancer patients expressing EGFR (EXTRA study)

被引：0

作者：

Morikawa, Kei ^{[1
]}

Takata, Saori ^{[2
]}

Tanaka, Hisashi ^{[3
]}

Horiuchi, Kazuya ^{[4
]}

Okuma, Yusuke ^{[5
]}

Soejima, Kenzo ^{[6
]}

Nakagawa, Hideyuki ^{[7
]}

Nakahara, Yoshiro ^{[8
]}

Seki, Yoshitaka ^{[9
]}

Bessyo, Akihiro ^{[10
]}

Takahashi, Nobumasa ^{[11
]}

Hayashi, Kentaro ^{[12
]}

Endo, Takeo ^{[13
]}

Takeyama, Ren ^{[14
]}

Maekura, Toshiya ^{[15
]}

Takigawa, Nagio ^{[16
]}

Horimoto, Katsuhisa ^{[17
]}

Matsutani, Noriyuki ^{[18
]}

Seki, Nobuhiko ^{[19
]}

机构：

[1] St Marianna Univ, Div Resp Dis, Dept Internal Med, Sch Med, Kawasaki, Kanagawa, Japan

[2] Kyorin Univ, Mitaka, Tokyo, Japan

[3] Hirosaki Univ, Hirosaki, Aomori, Japan

[4] Showa Univ, Northern Yokohama Hosp, Tokyo, Japan

[5] Natl Canc Ctr Hosp, Kashiwa, Chiba, Japan

[6] Keio Univ, Minato City, Japan

[7] Hirosaki Hosp, Hirosaki, Aomori, Japan

[8] Kitasato Univ, Minato City, Japan

[9] Jikei Univ, Hosp 3, Tokyo, Japan

[10] Okayama Red Cross Hosp, Okayama, Japan

[11] Saitama Cardiovasc & Resp Ctr, Saitama, Japan

[12] Nihon Univ, Chiyoda City, Japan

[13] Mito Med Ctr, Ibaraki, Japan

[14] Tokyo Womens Med Univ, Tokyo, Japan

[15] Hoshigaoka Med Ctr, Hirakata, Osaka, Japan

[16] Kawasaki Med Sch, Kawasaki, Kanagawa, Japan

[17] Natl Inst Adv Ind Sci & Technol, Tokyo, Japan

[18] Teikyo Univ, Mizonokuti Hosp, Kawasaki, Kanagawa, Japan

[19] Teikyo Univ, Tokyo, Japan

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.09.244

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MO35-6

引用

页码：S1418 / S1419

页数：2

共 50 条

[31] Afatinib After Progression on Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer
Aredo, Jacqueline, V
Wakelee, Heather A.
Neal, Joel W.
Padda, Sukhmani K.
CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2022, 30
[32] Afatinib in Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR Inhibitors
Heigener, David F.
Schumann, Christian
Sebastian, Martin
Sadjadian, Parvis
Stehle, Ingo
Maerten, Angela
Lueers, Anne
Griesinger, Frank
Scheffler, Matthias
ONCOLOGIST, 2015, 20 (10): : 1167 - 1174
[33] Invasive staging of non-small cell lung cancer -: a prospective study
Eggeling, S
Martin, T
Böttger, J
Beinert, T
Gellert, K
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2002, 22 (05) : 679 - 684
[34] A phase I pharmacokinetic study of matuzumab in combination with paclitaxel in patients with EGFR-expressing advanced non-small cell lung cancer
J. T. Hartmann
C. Kollmannsberger
I. Cascorbi
F. Mayer
M. M. Schittenhelm
S. Heeger
C. Bokemeyer
Investigational New Drugs, 2013, 31 : 661 - 668
[35] A phase I pharmacokinetic study of matuzumab in combination with paclitaxel in patients with EGFR-expressing advanced non-small cell lung cancer
Hartmann, J. T.
Kollmannsberger, C.
Cascorbi, I.
Mayer, F.
Schittenhelm, M. M.
Heeger, S.
Bokemeyer, C.
INVESTIGATIONAL NEW DRUGS, 2013, 31 (03) : 661 - 668
[36] Phase IV Study of Afatinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Thongprasert, Sumitra
Boldeanu, Cosmin
Radosavljevic, Davorin
Petrovic, Marina
Jones, Hilary
Cseh, Agnieszka
Gaafar, Rabab
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S667 - S667
[37] Clinical perspective of afatinib in non-small cell lung cancer
Chen, Xiaofeng
Zhu, Quan
Zhu, Lingjun
Pei, Dong
Liu, Yiqian
Yin, Yongmei
Schuler, Martin
Shu, Yongqian
LUNG CANCER, 2013, 81 (02) : 155 - 161
[38] Afatinib: A Review in Advanced Non-Small Cell Lung Cancer
Keating, Gillian M.
TARGETED ONCOLOGY, 2016, 11 (06) : 825 - 835
[39] Afatinib for the treatment of metastatic non-small cell lung cancer
Joshi, Monika
Rizvi, Syed M.
Belani, Chandra P.
CANCER MANAGEMENT AND RESEARCH, 2015, 7 : 75 - 82
[40] Afatinib treatment in advanced non-small cell lung cancer
Hurwitz, Jane L.
Scullin, Paula
Campbell, Lynn
LUNG CANCER-TARGETS AND THERAPY, 2011, 2 : 47 - 57

← 1 2 3 4 5 →